3 Cryptos to Buy for 2022
Is your crypto portfolio ready for 2022?

With Bitcoin hitting all-time highs, now is the time to reorient your crypto plays for the coming year.

That's why Luke Lango, InvestorPlace's resident crypto expert is releasing his latest calls… completely free.

You can get them in his latest report, "3 Cryptos to Beat Bitcoin."
Just click here to claim your copy today.

BGT Insider Trading (Bio-Gene Technology)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$10,181.89
Insider Selling (Last 12 Months): A$0.00

Bio-Gene Technology Insider Trading History Chart

This chart shows the insider buying and selling history at Bio-Gene Technology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bio-Gene Technology Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for BGT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
5 Free Dividend Stocks for 2022
Could these top payout stocks be part of the greatest wealth-creating tool in history?
Learn More.

Bio-Gene Technology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/26/2021Robert KlupacsInsiderBuy72,212A$0.14A$10,181.89
9/16/2020Peter MayInsiderSell45,242A$0.17A$7,464.93
7/30/2020Peter MayInsiderIssued528,235A$0.07A$35,919.98
6/22/2020Peter MayInsiderBuy16,129A$0.16A$2,500.00
3/1/2019Donald BrumleyInsiderBuy150,000A$0.10A$15,000.00
See Full Table
Insider Trading at Bio-Gene Technology?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Bio-Gene Technology and related companies.

SEC Filings (Institutional Ownership Changes) for Bio-Gene Technology (ASX:BGT)

Bio-Gene Technology Limited, a biotechnology company, engages in developing insecticides/pesticides for animal health, crop protection, public health, and consumer applications in Australia. It is involved in developing Flavocide, a beta-triketone insecticide product; and Qcide, a natural oil extracted from the leaves of rare eucalyptus trees. The company has a research collaboration agreement with James Cook University for the development of a tissue culture system to support the expansion of tree plantations and scale-up of future Qcide oil production. It also has collaborations with Pacific Discovery Services for studying Flavocide's mode of action; and the Queensland Department of Agriculture and Fisheries for assessing activity against grain storage pests. Bio-Gene Technology Limited was incorporated in 1995 and is based in Melbourne, Australia.
Read More on Bio-Gene Technology

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Bio-Gene Technology?

Bio-Gene Technology's top insider investors include:
  1. Peter May (Insider)
  2. Robert Klupacs (Insider)
Little-Known Stock Mints Money From Apple's iPhone
The one company 350x smaller than Apple that could capitalize on the potential collapse of the iPhone.
Learn More.